Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread
2007

Assessing the Danger of Neuraminidase Inhibitor Resistance in Influenza

publication Evidence: moderate

Author Information

Author(s): Andreas Handel, Ira M. Longini Jr., Rustom Antia

Primary Institution: Emory University

Hypothesis

How likely is it that an infected patient can generate a resistant infection in a secondary host, and how likely is it that the resistant strain subsequently spreads?

Conclusion

The initial generation of resistant cases is likely lower than previously reported, but the spread of resistance is influenced by the immune response and treatment timing.

Supporting Evidence

  • Neuraminidase inhibitors are the most effective drugs against influenza.
  • The study provides estimates for parameters that can be used in models to study resistance emergence.
  • Early treatment can reduce the generation of resistant strains.

Takeaway

This study looks at how resistant strains of the flu virus can spread and how treatment affects this. It finds that early treatment can help prevent resistance.

Methodology

The study combines data from human influenza infections with mathematical models to estimate parameters for resistance generation and spread.

Potential Biases

The models used may not accurately reflect the complexities of immune responses and viral dynamics.

Limitations

The study's results depend on estimates that come with significant uncertainty, particularly regarding within-host dynamics and the conversion rate between TCID50 and virions.

Participant Demographics

Data from human volunteers infected with influenza.

Digital Object Identifier (DOI)

10.1371/journal.pcbi.0030240

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication